3m conix dry powder inhaler designed and developed by cambridge consultants. it is a highperformance &lsquoreverse flow cyclone&rsquo inhaler technology for the delivery of dry powders to the lung. the technology was licensed to 3m drug delivery systems in december 2008 in an exclusive technology license and purchase agreement and has been developed in to single and multidose dpi platforms. this inhaler contains no moving parts or propellants. this is patientfriendly inhalers features effective drug aerosolization technology without electronics single and multidose dpis expand range of possible applications deliver efficacious dose to the lungs with low throat deposition.
